Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

The effect of interactions between genetics and cannabis use on neurocognition. A review.

Cosker E, Schwitzer T, Ramoz N, Ligier F, Lalanne L, Gorwood P, Schwan R, Laprévote V.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:95-106. doi: 10.1016/j.pnpbp.2017.11.024. Epub 2017 Nov 28. Review.

PMID:
29191570
2.

Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients.

Pompili M, Gentile G, Scassellati C, Bonvicini C, Innamorati M, Erbuto D, Montebovi F, Ducci G, Forte A, De Pisa E, Ferracuti S, Serafini G, De Luca V, Amore M, Simmaco M, Girardi P.

Neurosci Lett. 2017 Aug 24;656:94-102. doi: 10.1016/j.neulet.2017.07.020. Epub 2017 Jul 14.

PMID:
28716530
3.

Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.

Health Quality Ontario .

Ont Health Technol Assess Ser. 2017 Apr 11;17(4):1-39. eCollection 2017. Review.

4.

Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms.

Peitl V, Štefanović M, Karlović D.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:209-215. doi: 10.1016/j.pnpbp.2017.04.011. Epub 2017 Apr 14.

PMID:
28416295
5.

Associations between serotonin transporter and behavioral traits and diagnoses related to anxiety.

Talati A, Odgerel Z, Wickramaratne PJ, Norcini-Pala A, Skipper JL, Gingrich JA, Weissman MM.

Psychiatry Res. 2017 Jul;253:211-219. doi: 10.1016/j.psychres.2017.03.033. Epub 2017 Mar 21.

6.

Gene expression-based biological test for major depressive disorder: an advanced study.

Watanabe SY, Numata S, Iga JI, Kinoshita M, Umehara H, Ishii K, Ohmori T.

Neuropsychiatr Dis Treat. 2017 Feb 21;13:535-541. doi: 10.2147/NDT.S120038. eCollection 2017.

7.

Disorganization at the stage of schizophrenia clinical outcome: Clinical-biological study.

Nestsiarovich A, Obyedkov V, Kandratsenka H, Siniauskaya M, Goloenko I, Waszkiewicz N.

Eur Psychiatry. 2017 May;42:44-48. doi: 10.1016/j.eurpsy.2016.12.011. Epub 2016 Dec 30.

PMID:
28192769
8.

The serotonin transporter gene 5-HTTLPR polymorphism is associated with affective psychoses but not with schizophrenia: A large-scale study in the Russian population.

Golimbet V, Korovaitseva G, Lezheiko T, Abramova LI, Kaleda VG.

J Affect Disord. 2017 Jan 15;208:604-609. doi: 10.1016/j.jad.2016.10.020. Epub 2016 Oct 26.

PMID:
28029428
9.

A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.

Wang F, Mi W, Ma W, Ma C, Yang Y, Zhang H, Du B, Li K, Liu C, Wang L, Lu T, Zhang H, Lv L, Zhang D, Yue W.

Pharmacogenomics. 2015 Nov;16(17):1943-9. doi: 10.2217/pgs.15.133. Epub 2015 Nov 10.

PMID:
26556226
10.

A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors.

Baganz NL, Lindler KM, Zhu CB, Smith JT, Robson MJ, Iwamoto H, Deneris ES, Hewlett WA, Blakely RD.

Transl Psychiatry. 2015 Nov 3;5:e671. doi: 10.1038/tp.2015.168.

11.

Common variants of HTR1A and SLC6A4 confer the increasing risk of Schizophrenia susceptibility: A population-based association and epistasis analysis.

Lin H, Lei Y, Zhang B, Dai Z, Lu X.

Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):749-55. doi: 10.1002/ajmg.b.32380. Epub 2015 Sep 26.

PMID:
26408209
12.

Genetic Polymorphisms Might Predict Suicide Attempts in Mental Disorder Patients: A Systematic Review And Meta-Analysis.

de Medeiros Alves V, Bezerra DG, de Andrade TG, de Melo Neto VL, Nardi AE.

CNS Neurol Disord Drug Targets. 2015;14(7):820-7. Review.

PMID:
26166439
13.

Pharmacogenetics and antipsychotic treatment response.

Naumovska Z, Nestorovska AK, Filipce A, Sterjev Z, Brezovska K, Dimovski A, Suturkova LJ.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(1):53-67. Review.

PMID:
26076775
14.

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia.

Terzić T, Kastelic M, Dolžan V, Plesničar BK.

Neuropsychiatr Dis Treat. 2015 Feb 20;11:453-9. doi: 10.2147/NDT.S76494. eCollection 2015.

15.

A genetic variant in 12q13, a possible risk factor for bipolar disorder, is associated with depressive state, accounting for stressful life events.

Shimasaki A, Kondo K, Saito T, Esaki K, Otsuka Y, Mano K, Ikeda M, Iwata N.

PLoS One. 2014 Dec 17;9(12):e115135. doi: 10.1371/journal.pone.0115135. eCollection 2014.

16.

Specific and common genes implicated across major mental disorders: a review of meta-analysis studies.

Gatt JM, Burton KL, Williams LM, Schofield PR.

J Psychiatr Res. 2015 Jan;60:1-13. doi: 10.1016/j.jpsychires.2014.09.014. Epub 2014 Sep 28. Review.

PMID:
25287955
17.

Effects of quetiapine on DNA methylation in neuroblastoma cells.

Sugawara H, Bundo M, Asai T, Sunaga F, Ueda J, Ishigooka J, Kasai K, Kato T, Iwamoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:117-21. doi: 10.1016/j.pnpbp.2014.08.010. Epub 2014 Sep 3.

PMID:
25194461
18.

No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population.

Yang B, Huang X, Ruan L, Yu T, Li X, Jesse FF, Cao Y, Li X, Liu B, Yang F, Lee YS, He L, Li W, He G.

Neurosci Lett. 2014 Sep 5;579:114-8. doi: 10.1016/j.neulet.2014.07.004. Epub 2014 Jul 11.

PMID:
25019689
19.

Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.

Tybura P, Trześniowska-Drukała B, Bienkowski P, Beszlej A, Frydecka D, Mierzejewski P, Samochowiec A, Grzywacz A, Samochowiec J.

Psychiatry Res. 2014 Oct 30;219(2):261-7. doi: 10.1016/j.psychres.2014.05.039. Epub 2014 Jun 2.

PMID:
24930580
20.

Anxiety disorders and anxiety-related traits and serotonin transporter gene-linked polymorphic region (5-HTTLPR) in adolescents: case-control and trio studies.

Bortoluzzi A, Blaya C, Salum GA, Cappi C, Leistner-Segal S, Manfro GG.

Psychiatr Genet. 2014 Aug;24(4):176-80. doi: 10.1097/YPG.0000000000000035.

PMID:
24842237

Supplemental Content

Loading ...
Support Center